News

Thanks to the 2025 Frank Murphy Travelling Scholarship, Dr Hall presented at one of the world’s biggest international conferences in health economics.

Exploring the intersection of stress and addiction in women’s mental health

Thanks to a $1.97 million MRFF grant, Monash University researchers are set to launch a large-scale, multidisciplinary project that takes a contemporary approach to preventing substance use and mental health problems.

Thank you to all who have been part of our story for the past 30 years! Since 1995, Turning Point has been at the forefront of responding to health reforms, delivering high-quality services, and shaping the conversation on addiction.

Master of Addictive Behaviours graduate Nic Robinson-Griffith has published his award-winning thesis on transgender and gender diverse inclusion in AOD residential treatment.

A new report is shedding light on the relationship between sleep quality, sleep-wake cycle patterns, and methamphetamine use disorder in women.

Don’t miss the new podcast from JOY Media's ‘Well Well Well’ with Turning Point and Thorne Harbour Health

We’re delighted to announce that Professor Victoria Manning has secured $1.9 million in funding from the National Health and Medical Research Council and the Ramsay Hospital Research Foundation to lead an innovative trial set to transform alcohol treatment for thousands of Australians.

The 2025 Margaret Hamilton Travelling Scholarship recipient presented findings from an open-label pilot study of oxytocin for methamphetamine withdrawal in women.

Researchers from Turning Point, Ambulance Victoria and Monash University have uncovered a surge in GHB-related ambulance attendances across Victoria, with Greater Geelong emerging as a regional hotspot.

The Master of Addictive Behaviours equips you with the specialist knowledge and practical skills to enhance your professional practice and help transform addiction policy, programs and services.

Researchers from Turning Point and Monash University have launched a ground-breaking new trial that combines neuroscience, technology and clinical care to tackle alcohol dependence.